The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 15, 2025

Filed:

Jun. 19, 2023
Applicants:

Bruin Biosciences, Inc., San Diego, CA (US);

The Regents of the University of California, Oakland, CA (US);

Inventors:

James Na, San Diego, CA (US);

David Imagawa, Oakland, CA (US);

Fabio Tucci, San Diego, CA (US);

Graham Beaton, San Diego, CA (US);

Satheesh Ravula, San Diego, CA (US);

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/127 (2025.01); A61K 9/1277 (2025.01); A61K 9/14 (2006.01); A61K 9/50 (2006.01); A61K 31/404 (2006.01); A61K 31/44 (2006.01); A61K 31/47 (2006.01); A61K 31/53 (2006.01); A61K 47/24 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/127 (2013.01); A61K 9/1277 (2013.01); A61K 9/146 (2013.01); A61K 9/5026 (2013.01); A61K 31/404 (2013.01); A61K 31/44 (2013.01); A61K 31/47 (2013.01); A61K 31/53 (2013.01); A61K 47/24 (2013.01); A61P 35/00 (2018.01);
Abstract

Described herein is a chemoembolization therapy, which combines therapeutic effects of peripheral arterial occlusion with the local administration of an anti-cancer agent. A particle or microsphere occludes the arteries providing blood flow to the tumor, resulting in tumor oxygen deprivation. The anti-angiogenic agent is an anti-cancer drug, as described herein.


Find Patent Forward Citations

Loading…